Stay updated on Nebulized Fentanyl in ILD Patients Clinical Trial
Sign up to get notified when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.

Latest updates to the Nebulized Fentanyl in ILD Patients Clinical Trial page
- Check3 days agoChange DetectedLocations section added with Ontario as a study site. The HHS Vulnerability Disclosure and Ontario Locations sections were removed; page revision updated to v3.3.3.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows a minor revision tag update from v3.2.0 to v3.3.2; there are no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe government funding/operating status banner has been removed from the page, a change that does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedVisual/UI updates are present, but there are no changes to core study details (protocol, eligibility criteria, endpoints, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference4%

- Check89 days agoChange DetectedAdds update label (v3.1.0) and removes several drug-safety sections (Drug Safety, Substandard Drugs, Counterfeit Drugs) from the page.SummaryDifference0.7%

Stay in the know with updates to Nebulized Fentanyl in ILD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.